Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial
Abstract Background Sildenafil is the drug of choice for neonatal pulmonary hypertension in developing countries where inhaled nitric oxide is not available. Available as oral and intravenous preparation - no study has been done in the past to compare the two forms. Each has its own benefits - but r...
Saved in:
Main Authors: | Chinmay Chetan (Author), Pradeep Suryawanshi (Author), Suprabha Patnaik (Author), Naharmal B. Soni (Author), Chandra Rath (Author), Prince Pareek (Author), Bhvya Gupta (Author), Reema Garegrat (Author), Arjun Verma (Author), Yogen Singh (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pilot randomized controlled trial comparing noradrenaline and adrenaline as a first-line vasopressor for fluid-refractory septic shock in neonates
by: Reema Garegrat, et al.
Published: (2024) -
Diagnostic utility of lung ultrasound in predicting the need for surfactant therapy in preterm neonates with respiratory distress
by: Pari Singh, et al.
Published: (2023) -
Hemodynamic parameters after Delayed Cord Clamping (DCC) in term neonates: a prospective observational study
by: Bhvya Gupta, et al.
Published: (2022) -
Oral sildenafil versus bosentan for treatment of persistent pulmonary hypertension of the newborn: a randomized controlled trial
by: Aditya Kallimath, et al.
Published: (2024) -
Congenital dyserythropoietic anemia type IV with kruppel-like factor 1 E325K mutation in a preterm neonate: Case and literature review
by: Reema Garegrat, et al.
Published: (2022)